Why Atara Biotherapeutics Inc (ATRA) Stock Is Rising
As of 2026-09-08, Atara Biotherapeutics Inc (ATRA) has a next-year EPS growth estimate of 236.15%. Featured in our EPS revision report on 2026-09-08.
Why ATRA Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Atara Biotherapeutics Inc's next-year EPS growth estimate from 156.43% to 236.15% on 2026-08-31.
- ·Current-Year Growth: Projected at -126.90%, supporting the forward estimate revision.
News Context
The primary structural driver is the next-year EPS growth estimate upgrade from 156.43% to 236.15% on 202
Generated 2026-09-08 · news as of 2026-09-08
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 236.15%
- EPS growth this year
- -126.90%
- EPS next quarter (est)
- -$0.13
- Last price
- $10.23
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-08 | 236.15% | -126.90% | -$0.13 | $10.23 |
| 2026-09-07 | 236.15% | -126.90% | -$0.13 | $9.76 |
| 2026-09-06 | 236.15% | -126.90% | -$0.13 | $9.76 |
| 2026-09-04 | 236.15% | -126.90% | -$0.13 | $9.76 |
| 2026-09-03 | 236.15% | -126.90% | -$0.13 | $9.53 |
| 2026-09-02 | 236.15% | -126.90% | -$0.13 | $9.44 |
| 2026-09-01 | 236.15% | -126.90% | -$0.13 | $9.02 |
| 2026-08-31 | 236.15% | -126.90% | -$0.13 | $8.90 |
| 2026-08-30 | 156.43% | -127.70% | -$0.14 | $9.20 |
| 2026-08-29 | 156.43% | -127.70% | -$0.14 | $9.20 |
| 2026-08-28 | 156.43% | -127.70% | -$0.14 | $9.20 |
| 2026-08-27 | 156.43% | -127.70% | -$0.14 | $9.25 |
| 2026-08-26 | 156.43% | -127.70% | -$0.14 | $9.38 |
| 2026-08-25 | 156.43% | -127.70% | -$0.14 | $9.84 |
| 2026-08-24 | 156.43% | -127.70% | -$0.14 | $9.46 |
| 2026-08-23 | 156.43% | -127.70% | -$0.14 | $9.70 |
| 2026-08-21 | 142.77% | -145.49% | -$0.28 | $9.70 |
| 2026-08-20 | 142.77% | -145.49% | -$0.28 | $9.38 |
| 2026-08-19 | 142.77% | -145.49% | -$0.28 | $9.60 |
| 2026-08-18 | 142.77% | -145.49% | -$0.28 | $8.72 |
| 2026-08-17 | 142.77% | -145.49% | -$0.28 | $8.36 |
| 2026-08-16 | 142.77% | -145.49% | -$0.28 | $8.09 |
| 2026-08-14 | 142.77% | -145.49% | -$0.28 | $8.09 |
| 2026-08-13 | 154.40% | -146.85% | -$0.30 | $8.51 |
| 2026-08-12 | 169.11% | -150.39% | -$0.32 | $9.23 |
| 2026-08-11 | 169.11% | -150.39% | -$0.32 | $8.94 |
| 2026-08-10 | 169.11% | -150.39% | -$0.32 | $8.61 |
| 2026-08-09 | 169.11% | -150.39% | -$0.32 | $8.45 |
| 2026-08-07 | 169.11% | -150.39% | -$0.32 | $8.45 |
| 2026-08-06 | 169.11% | -150.39% | -$0.32 | $8.25 |
Reports Featuring ATRA
Recent News
- Atara Biotherapeutics: Q1 Earnings SnapshotAssociated Press
- Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational ProgressBusiness Wire
- FDA Resubmission Path for Tab-cel Keeps Ataras (ATRA) Regulatory Timeline AliveInvestorsHub
- FDA Resubmission Path for Tab-cel Keeps Ataras (ATRA) Regulatory Timeline AliveInvestorsHub
- BC-Most Active StocksAssociated Press
- Atara Biotherapeutics Provides Regulatory Update on TabelecleucelBusiness Wire
- Atara Biotherapeutics Provides Regulatory Update on TabelecleucelBusiness Wire
Screen Performance
Aggregate stats across all 2030 tickers our top-EPS-revision screen has flagged over the past 160 days.
- Median return since detection
- +2.1%
- % of tickers in the green
- 54%
- Median return on winners
- +21.0%
- Large revisions captured
- 1676
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Atara Biotherapeutics Inc (ATRA) stock go up recently?▾
Atara Biotherapeutics Inc (ATRA) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 156.43% to 236.15% on 2026-08-31. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Atara Biotherapeutics Inc's next-year EPS growth estimate?▾
As of 2026-09-08, Atara Biotherapeutics Inc (ATRA) has a next-year EPS growth estimate of 236.15%, based on analyst consensus.
When was the latest EPS estimate revision for ATRA?▾
The most recent revision occurred on 2026-08-31, when analysts adjusted the next-year EPS growth estimate from 156.43% to 236.15%.
What sector and industry does Atara Biotherapeutics Inc belong to?▾
Atara Biotherapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ATRA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Atara Biotherapeutics Inc (ATRA) appears here because it was detected by our daily top-EPS-revision-performer screen.